Actively Recruiting
Biologics for Stricturing Crohn's Diseases
Led by Jinling Hospital, China · Updated on 2023-05-11
200
Participants Needed
1
Research Sites
417 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Recent researches have reported that biologics might be also effective for stricturing CD. However, the data were largely retrospective. Prospective studied are needed for evaluate the efficacy of biologics for stricturing Crohn's diseases.
CONDITIONS
Official Title
Biologics for Stricturing Crohn's Diseases
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with stricturing Crohn's disease
- No current surgical indication
- Patients with asymptomatic penetrating disease
- Written consent obtained
You will not qualify if you...
- Patients with surgical indication
- Patients with symptomatic penetrating disease
- Contraindication to biologics
- Planning to participate in another trial
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Department of General Surgery, Jinling hosptal,Medical School of Nanjing University
Nanjing, Jiangsu, China, 210002
Actively Recruiting
Research Team
W
Weiming wm Zhu, Ph.D.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here